Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

FUNDACION SEIMC GESIDA

Home Clinical Trial Sponsors and OrganizationsFUNDACION SEIMC GESIDA

FUNDACION SEIMC GESIDA

CALLE AGUSTIN DE BETANCOURT 13, Madrid, Spain

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Clinical Trials

37

8 active

Approvals

0

Total approvals

Agencies

0

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Share

Phase 4

18

48.6%

Phase 1

4

10.8%

Not Applicable

2

5.4%

Phase 2

2

5.4%

Trial Status Distribution

Active, not recruiting

7

18.9%

Completed

26

70.3%

Not yet recruiting

1

2.7%

Recruiting

1

2.7%

Unknown

1

2.7%

Withdrawn

1

2.7%

Clinical Trials

Trials sponsored by this organization (37)

Effect of Extra Virgin Olive Oil Consumption on the Occurrence of Cardiovascular Events in Population Living With HIV

Not yet recruiting

Oct 20261,324 participants

GRAM NEGATIVES STUDY

Mar 20261,500 participants

Clinical Trial to Evaluate the Safety and Appropriateness of Switching from Dolutegravir/Lamivudine to Bictegravir/Emtricitabine/Tenofovir Alafenamide in People With HIV, Good Control and Neuropsychiatric Vulnerabilities: MIND Study

Active, not recruiting

Apr 202484 participants

Study to Evaluate the Efficacy and Safety of a Rilpivarine-based Antiretroviral Tratment Regimen in HIV- Infected Patients With Liver Metabolic Disease Who Maintain Udetectable HIV Viral Load

May 202363 participants

Phase IV comparative, randomized, open-label pilot study to evaluate the efficacy and safety of a rilpivirine-based antiretroviral treatment regimen in HIV-infected patients with metabolic liver disease who maintain undetectable HIV viral load

Active, not recruiting

Jan 202375 participants

Phase IV, a Clinical Trial to Assess Safety and Convenience of the Change From DTG/3TC to BIC/FTC/TAF in People With HIV, Good Virological Control and Neuropsychiatric Vulnerabilities

Oct 202284 participants

Simplified Model of Linkage and Retention to Care, Using a Mobile Unit and a Same-day Test and Treat Approach Among Excluded Population. (SIMPLIFIED)

Jul 2022101 participants

Lamivudine/Dolutegravir in Virologically Suppressed Subjects With Expected or Confirmed Resistance to Lamivudine

Jul 2021167 participants

Page 1 of 5

Approvals

No approval data available

News

No news articles found

On this page

Overview
Clinical Trials37
Approvals
News

Back to Organizations